About
Point Biopharma develops targeted radiopharmaceutical therapies for precise cancer treatment, focusing on advancing alpha-emitting and other radiopharmaceutical technologies.
Explore Point Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.